Stock ELEVEN BIOTHERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Eleven Biotherapeutics Inc Nasdaq

Equities

US2862211065

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, A Novel HER2-Targeting CAR-Monocyte
CI
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
AQ
Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference
PR
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
PR
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
CI
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy Annual Meeting
AQ
BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target
MT
Carisma Therapeutics to Present at Upcoming Conferences
PR
HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating
MT
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Carisma Therapeutics Q4 Net Loss Narrows, Revenue Rises; Plans Job Cuts in Q2 -- Shares Decline
MT
Carisma Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Carisma Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Carisma Therapeutics Announces Changes to its Board of Directors
PR
Carisma Therapeutics, Inc. Announces Changes to Its Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CARM Stock
  4. Stock
  5. News Eleven Biotherapeutics Inc
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW